A Diverse & Inclusive Workplace
Sanofi respects the diversity of its people and works to create an inclusive workplace where everyone can be their true selves. Its employees represent the variety of Sanofi’s patients, customers and partners, which builds a better understanding of needs and forges stronger connections. Sanofi people dare to be themselves and to celebrate their differences, be it race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; or veteran or military status, in an environment that helps them achieve their full potential.
We Are Sanofi
Inclusion Cafe Podcast #1 Black Lives Matter
One Face, One Story
Sanofi launched SanofiPridePlus, a global colleague resource group that aims to provide community and resources for LGBTQ employees, raise their voices within the company, and educate allies and friends in the cause of LGBTQ equality.
Diversity in Clinical Trials
Sanofi is working to address current challenges in the recruitment of individuals from diverse populations to clinical trials, such as using broader participant eligibility criteria. Our clinical studies are designed to identify the patient population that may benefit the most from the investigational drug. To that end, we do not exclude participants based on minority status, gender, sexual orientation or age. In addition, although comorbidities can bring increased risk to trial participants, we have been making our trials more inclusive by not excluding patients with comorbidities wherever we can. We are also actively working to both enhance the selection of trial sites to include more diverse population-dense communities and to involve more diverse investigators with the goal of further increasing minority participation in our trials.
In sum, Sanofi believes that to improve both social equity and human health, we should continue to increase the participation of diverse populations in clinical trials by identifying barriers to recruitment, enrollment and retention, and employing strategies that encourage participants from these diverse populations.